The Chief Executive Officer of Delta 9 Cannabis (Other OTC: DLTNF) is Buying Shares

Today, the Chief Executive Officer of Delta 9 Cannabis (DLTNFResearch Report), Iv John William (John) Arbuthnot, bought shares of DLTNF for $2,900.

See today’s analyst top recommended stocks >>

Based on Delta 9 Cannabis’ latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $14.15 million and GAAP net loss of -$3,666,833. In comparison, last year the company earned revenue of $10.59 million and had a GAAP net loss of $3.12 million. DLTNF’s market cap is $46.39 million and the company has a P/E ratio of -7.20.

The insider sentiment on Delta 9 Cannabis has been positive according to 12 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Delta 9 Cannabis, Inc. is a vertically integrated cannabis company, which engages in the production of medical and recreational cannabis products. Its products include kami mist, brooklyn sunrise, sesi star, and oil and sprays. The company was founded by John William Arbuthnot III and John William Arbuthnot IV in 2012 and is headquartered in Winnipeg, Canada.